Global leukemia therapeutics market was valued USD18584.23 Million in 2020 and is expected to grow at a CAGR of 7.47% during the forecast period. The global leukemia therapeutics market is driven by the technological advancements and innovations in the field of blood cancer testing on account of the growing number of patients suffering from leukemia. Additionally, growing awareness among the population pertaining to adoption of preventive healthcare is further expected to propel the market during forecast period. Supportive government initiatives and policies for promoting cancer awareness are anticipated to fuel the market growth until 2026.
Leukemia or blood cancer is the cancer of blood forming tissuesbone marrow and lymphatic system. As the name suggests, it affects the leucocytes or white blood cells. In this type of cancer, the DNA of leucocytes gets damaged as a result of which they grow and divide uncontrollably. These cells keep on growing and start accumulating, thereby preventing the healthy white blood cells from growing and functioning.
The global leukemia therapeutics market can be segmented based on
Regionally, the leukemia therapeutics market
Major players operating in the global leukemia therapeutics market include Novartis AG, AbbVie Inc., Roche Holding AG, Amgen Inc., AstraZeneca PLC, Pfizer Inc., Merck & Company Inc., Eli Lilly and Company Ltd., Bristol-Myers Squibb Company, Gilead Sciences Inc., Astellas Pharma Inc., Takeda Pharmaceutical Company Ltd., Stemline Therapeutics Inc.,
Years considered for this report
Historical Years2016-2019
Base Year2020
Estimated Year2021
Forecast Period2022– 2026
Objective of the Study
- To analyze historical growth in market size of global leukemia therapeutics market from 2016 to 2020.
- . To estimate and forecast the market size of global leukemia therapeutics market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast global leukemia therapeutics market based on factor, severity, blood cell, age groups, gender, treatment, diagnosis, route of administration, drugs, company and regional distribution.
- To identify drivers and challenges for global leukemia therapeutics market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global leukemia therapeutics market.
- To identify and analyze the profiles of leading players operating in global leukemia therapeutics market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Leukemia drugs manufacturers, suppliers, distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to leukemia therapeutics
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
